Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Name: Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Published: 2016
License: Public Domain

University of Ulm · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

acute myeloid leukemia (aml), high-risk myelodysplastic syndrome (mds), volasertib, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Related documents